In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From the US Most Favored Nation (MFN) policy and Germany's Medical Research Act to surprising developments in Japan's pricing thresholds, Nikhil breaks down how these changes are reshaping pricing and reimbursement strategies worldwide. The conversation covers emerging regional patterns across Europe, North America, and ...
All content for Market Access Matters is the property of Access Infinity and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From the US Most Favored Nation (MFN) policy and Germany's Medical Research Act to surprising developments in Japan's pricing thresholds, Nikhil breaks down how these changes are reshaping pricing and reimbursement strategies worldwide. The conversation covers emerging regional patterns across Europe, North America, and ...
Finding fun in Market Access with Khalid Mirza, Daiichi Sankyo
Market Access Matters
29 minutes
1 year ago
Finding fun in Market Access with Khalid Mirza, Daiichi Sankyo
In the third episode of series 2, Louise interviews Khalid Mirza, Senior Director, Global Market Access & Pricing, Oncology at Daiichi Sankyo. They discuss Khalid's journey into market access, and how, for him, it's evolved into an exciting career path where science meets commercial. They also touch on the key themes shaping the future of market access, where Khalid's positive energy and passion for the function shines. The opinions shared in this episode are Khalid's ...
Market Access Matters
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From the US Most Favored Nation (MFN) policy and Germany's Medical Research Act to surprising developments in Japan's pricing thresholds, Nikhil breaks down how these changes are reshaping pricing and reimbursement strategies worldwide. The conversation covers emerging regional patterns across Europe, North America, and ...
